PORSCHA BRANCH: Open Payments
NPI 1104316819 · TEXARKANA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 11 payments from 8 companies in 2025. Trend: 2023 $362 · 2024 $136 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $94 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Lilly USA, LLC | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: FREESTYLE LIBRE 3, REXULTI, CAPLYTA, FANAPT, Quviviq, INGREZZA, VRAYLAR.
Industry payments across AR — which companies pay providers there.
